Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04925986
Title Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sarah Goldberg

lung non-squamous non-small cell carcinoma


Pembrolizumab + Sitravatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST